Best Mole mapping and digital dermoscopy for mole assessment Doctors Worldwide — TOP 31

Chief physician and professor. Grade 1 Expert at the Cancer Center, West China Hospital, Sichuan University (ranked No. 2 in China). Completed a postdoctoral fellowship in interventional radiology at the Chinese PLA General Hospital. Leads multidisciplinary team (MDT) care for complex tumors. Expert in minimally invasive interventional oncology for liver, lung, and pancreatic cancers.

Accreditations: Council Member, WATA. Member of CACA and CMDA committees on intervention, ablation, radioactive seeds, and pain. In 2023, inaugural director member, Palliative Care Committee, Sichuan MDA. Editorial board member of the Chinese Journal of Interventional Imaging and Therapy. Editorial board member of the Chinese Journal of Pain Medicine.

Leads 2 provincial S&T projects and 2 NSFC projects. Has 40+ papers, with 30+ as first or corresponding author. Highest impact factor: 10.73. Hepatocellular carcinoma (HCC) cohort: TACE + lenvatinib vs TACE + sorafenib. OS 18.97 vs 10.77 months. PFS 10.6 vs 5.4 months. ORR 66.8% vs 33.3%.

Dr. Anar Mahmudov is a dermatologist at Liv Bona Dea Hospital Baku. He specializes in clinical dermatology and aesthetic procedures. He completed his residency and postgraduate training at Sechenov Moscow Medical University. Dr. Mahmudov treats skin diseases, hair disorders, and performs hair transplantations.

• Practices at a JCI-accredited facility with 100% compliance standards.
• Performs anti-aging injection treatments including Botox, fillers, and thread lifting.
• Removes skin growths such as papillomas and moles using digital dermoscopy.
• Expertise includes various laser-based therapies and device-assisted cosmetology.

Professor Luo Xiaoping is a nationally recognized interventional radiologist and a leading authority in Western China. He began pioneering vascular interventions in the early 1990s. He helped found the Interventional Group at the Second Affiliated Hospital of Chongqing Medical University.

He has completed over 100,000 interventional procedures, including about 4,000 complex cases. His key skills include TACE for hepatocellular carcinoma, Budd–Chiari interventions, TIPS, and single-stage bilateral stenting for hilar biliary obstruction, with success rates near 100%. He has been a master’s supervisor since 2007. He has trained many physicians, guided complex cases at more than 40 major hospitals across Western China, and helped build interventional programs. He has published 32 papers as first or corresponding author (22 CSCD core, 4 Chinese core, 6 CSCD extended).

Dr. Dov Zippel is a surgical oncologist and head of the Meirav Breast Center. Forbes Israel named him to its Best Doctors list in 2025. He treats benign and malignant breast tumors and melanoma at Sheba Medical Center. Dr. Zippel completed a surgical oncology fellowship at the University of Calgary in Canada.

• Performs breast-conserving surgery and minimally invasive skin cancer procedures.
• Treats patients at the Ella Lemelbaum Institute for Immuno-Oncology.
• Researches perioperative treatments for stage III melanoma and breast lesion excision.
• Works at Sheba Medical Center, ranked 7th worldwide by Newsweek in 2026.

Professor Xiao Yueyong is Chief Physician in the Department of Radiological Diagnosis at the Chinese PLA General Hospital. He is a leading expert in minimally invasive interventional oncology. He serves as the inaugural President of WATA (2025–). He is President of the International (2020–) and Asian (2012–) Societies of Cryotherapy. He is also Deputy Head of the NHC Expert Group on tumour ablation regulations (2009–).

He has performed over 100,000 CT/MRI‑guided minimally invasive procedures. His work covers chemical ablation, RFA, MWA, cryoablation, and NanoKnife (IRE). He introduced and advanced NanoKnife ablation in China. He led the first national standards for tumour cryoablation and NanoKnife.

Honors include the National Special Contribution Award (Lifetime Honorary). He received First Prize from the Chinese Medicine Education Association (2021). He received two Second Prizes for Military Medical Achievements (2016, 2018) and two Second Prizes from the China Anti‑Cancer Association (2019, 2022). He was named Asian Ablation Master. His research record includes 13 Chinese patents. He is the principal investigator for four NSFC projects and one MOST subject. He has published over 200 papers, with over 110 as first or corresponding author and over 40 in SCI journals. He has led over 10 ablation guidelines or consensus statements.

Dr. Asli Tatliparmak is an associate professor of dermatology at Memorial Bahçelievler Hospital. She is a recognized editor of two international medical books. Dr. Tatliparmak specializes in medical aesthetics and complex skin pathologies. She is a member of the European Academy of Dermatology and Venereology.

• Performs laser skin resurfacing, Botox injections, and advanced jawline contouring.
• Authored or co-authored 50 scientific publications in international and national journals.
• Served as the former Head of Dermatology at İstinye University Liv Hospital.
• Winner of the Best Oral Presentation Award at the Aegean Dermatology Days.

Dr. Tamara Kopp is a consultant dermatologist at Wiener Privatklinik in Vienna. She combines clinical precision with aesthetic dermatology for personalized skin health. Dr. Kopp previously held a senior role at a leading dermatology clinic. She completed her specialist training at the Vienna General Hospital.

• Performs digital mole mapping and skin cancer screening with dermoscopy.
• Treats clinical conditions such as psoriasis, neurodermatitis, and alopecia.
• Provides aesthetic treatments including laser therapy, fillers, and Botox.
• Practices at Wiener Privatklinik, ranked among the World's Best Hospitals by Newsweek.

Dr. Christiane Thallinger is a specialist in skin cancer and oncologic dermatology at Wiener Privatklinik. She is a recognized expert in treating melanoma and basal cell carcinoma in Austria. Dr. Thallinger focuses on managing skin complications caused by cancer therapies. She previously served as a senior physician at the Medical University of Vienna.

• Performs digital mole mapping and dermoscopy for early skin cancer detection.
• Treats complex skin reactions induced by chemotherapy and immunotherapy.
• Performs surgical tumor excision, cryotherapy, and photodynamic therapy.
• Conducts research on immune-related skin toxicities to improve patient outcomes.

Dr. Ehsan Sotoudeh is a general surgeon and aesthetic expert at Eden Aesthetics. He uses advanced mole mapping and digital dermoscopy for precise skin assessments.

• Individualizes treatment planning to ensure safety and measurable results
• Holds an official license in regenerative medicine and stem cell therapy
• Uses a physician-led medical framework for all diagnostic procedures
• Focuses on precision medicine to provide outstanding patient outcomes

Dr. Muhammed Mustafa Atci is an Associate Professor of Medical Oncology at Liv Hospital Topkapı. He specializes in treating colon, breast, gastric, and lung cancers. He previously served as the Education Coordinator at Prof. Dr. Cemil Taşcıoğlu City Hospital. Dr. Atci is a member of the American Society of Clinical Oncology (ASCO).

• Author of 19 peer-reviewed papers on gastrointestinal, thoracic, and endocrine cancers.
• Published studies on survival outcomes for stage IIB colon cancer in the Journal of Chemotherapy.
• Researches prognostic biomarkers using PET/CT scans and metabolic tumor volume.
• Treats complex oncological cases at the university-affiliated İstinye University clinic.

Dr. Theodoulos Drousiotis is a dermatovenereologist at the German Medical Institute in Cyprus. He completed a Senior Skin Cancer Fellowship at St John’s Institute of Dermatology in London. Dr. Drousiotis specializes in melanoma screening, skin surgery, and aesthetic rejuvenation. He is a member of the European Academy of Dermatology and Venereology.

• Trained at Sheba Medical Centre, a facility often ranked among the best globally.
• Treats skin cancers, including basalioma and melanoma, using digital dermoscopy and mole mapping.
• Performs aesthetic procedures like Morpheus8, hyaluronic acid fillers, and laser scar removal.
• Teaches medical students at King’s College London and the University of Glasgow.

Dr. Jair Bar is a thoracic oncologist and Deputy Director of the Cancer Center at Sheba Medical Center. He specializes in treating advanced non-small cell lung cancer using personalized immunotherapy and targeted treatments. Dr. Bar holds a PhD in Molecular Biology and leads a research lab focused on immunotherapy resistance.

• Chair of the Israel Lung Cancer Group.
• Board-certified in both Medical Oncology and Radiotherapy Oncology.
• Treats patients at Sheba Medical Center, a top-10 globally ranked hospital.
• Uses molecular and genetic profiling to create precise cancer treatment plans.